parthenolide has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, N; Chen, Y; Ding, Y; Ge, W; Han, F; Hao, X; Liu, Z; Wang, M; Wang, T; Zhang, Q | 1 |
| Araújo, TG; Brandão, DC; Campos, IM; Ferreira, EA; Filho, AADS; Guimarães, GS; Lima, PMAP; Ribeiro, MA; Vecchi, L | 1 |
| Jin, X; Lu, X; Lv, H; Zhang, Z | 1 |
| Baldacchino, S; De Blasio, A; Di Fiore, R; Drago-Ferrante, R; Grech, G; Pratelli, G; Saliba, C; Scerri, C; Tesoriere, G; Vento, R | 1 |
1 review(s) available for parthenolide and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Parthenolide and its Analogues: A New Potential Strategy for the Treatment of Triple-Negative Breast Tumors.
Topics: Apoptosis; Cell Line, Tumor; Humans; Neoplasm Recurrence, Local; Sesquiterpenes; Triple Negative Breast Neoplasms | 2020 |
3 other study(ies) available for parthenolide and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Chemistry Techniques, Synthetic; Humans; Sesquiterpenes; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2019 |
Indocyanine Green-Parthenolide Thermosensitive Liposome Combination Treatment for Triple-Negative Breast Cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Delivery Systems; Endocytosis; Female; Humans; Hydrodynamics; Indocyanine Green; Liposomes; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Photosensitizing Agents; Reactive Oxygen Species; Sesquiterpenes; Temperature; Tissue Distribution; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Burden | 2020 |
A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells.
Topics: Cell Line, Tumor; Cell Proliferation; Cyclin D2; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; NF-E2-Related Factor 2; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction; Triple Negative Breast Neoplasms; Tumor Suppressor Proteins | 2020 |